<?xml version="1.0" encoding="UTF-8"?>
<ref id="hep41310-bib-0018">
 <label>18</label>
 <mixed-citation publication-type="journal" id="hep41310-cit-0018">
  <string-name>
   <surname>Kim</surname>
   <given-names>DD</given-names>
  </string-name>, 
  <string-name>
   <surname>Hutton</surname>
   <given-names>DW</given-names>
  </string-name>, 
  <string-name>
   <surname>Raouf</surname>
   <given-names>AA</given-names>
  </string-name>, 
  <string-name>
   <surname>Salama</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Hablas</surname>
   <given-names>A</given-names>
  </string-name>, 
  <string-name>
   <surname>Seifeldin</surname>
   <given-names>IA</given-names>
  </string-name>, et al. 
  <article-title>Cost‐effectiveness model for hepatitis C screening and treatment: implications for Egypt and other countries with high prevalence</article-title>. 
  <source xml:lang="en">Glob Public Health</source>
  <year>2015</year>;
  <volume>10</volume>:
  <fpage>296</fpage>‐
  <lpage>317</lpage>.
  <pub-id pub-id-type="pmid">25469976</pub-id>
 </mixed-citation>
</ref>
